Saturday, June 3, 2023
iBodyCBD
  • Home
  • CBD News
  • Wellness
    • CBD Wellness
    • CBD Anxiety
    • CBD Oil
  • Cannabis
    • Medical Marijuana
    • cbd benefits
    • CBD Health
    • THC
  • Food & Nutrition
    • keto
    • smoothies
    • herbal nutrition
  • Fitness
    • Exercise
    • Workout tips
  • Lifestyle
    • Keto diet
    • intermittent fasting
    • Hemp
    • Hemp Seed
  • Shop
No Result
View All Result
ibodyCBD
  • Home
  • CBD News
  • Wellness
    • CBD Wellness
    • CBD Anxiety
    • CBD Oil
  • Cannabis
    • Medical Marijuana
    • cbd benefits
    • CBD Health
    • THC
  • Food & Nutrition
    • keto
    • smoothies
    • herbal nutrition
  • Fitness
    • Exercise
    • Workout tips
  • Lifestyle
    • Keto diet
    • intermittent fasting
    • Hemp
    • Hemp Seed
  • Shop
No Result
View All Result
ibodyCBD
No Result
View All Result
Home THC

IGC (IGC) Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

nickymay by nickymay
June 8, 2021
in THC
0
305
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

Related articles

90 oz. of marijuana, gun seized during traffic stop – WPRI.com

Criminal complaints: Sept. 20-24 | Crime and Courts

[ad_1]


Get prompt alerts when information breaks in your shares. Declare your 1-week free trial to StreetInsider Premium here.


India Globalization Capital, Inc. (“IGC”) (NYSE American: IGC) pronounces at the moment that it has accomplished Cohort 2 of its Part 1 medical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, supposed to alleviate the signs of people affected by Alzheimer’s illness. As beforehand disclosed, IGC submitted IGC-AD1 to the U.S. Meals and Drug Administration (“FDA”) underneath Part 505(i) of the Federal Meals, Drug, and Beauty Act. IGC acquired approval to proceed with the trial from the FDA on July 30, 2020.

As beforehand introduced, for Cohort 1, we administered one dose of the investigational new drug IGC-AD1 per day to trial contributors. We elevated the dosage to 2 doses of IGC-AD1 per day in Cohort 2, which was performed from early February 2021 by means of mid-Might 2021. The Knowledge and Security Monitoring Committee (“DSMC”) for IGC’s medical trial, having reviewed the information obtained by means of Cohort 1 and Cohort 2, beneficial progressing to Cohort 3, which consists of administering three doses per day. Contributors are monitored day by day for security and sure behavioral adjustments utilizing, amongst others, the Neuropsychiatric Stock (NPI) scale and the Columbia-Suicide Severity Ranking Scale (C-SSRS). The Part 1 medical trial on Alzheimer’s sufferers is presently anticipated to conclude throughout the July by means of September 2021 timeframe.

To IGC’s data, that is the primary human medical trial utilizing low doses of pure THC, a psychoactive member of the cannabinoid class of pure merchandise produced by the Hashish sativa plant, on Alzheimer’s sufferers. IGC is happy to progress into Cohort 3 of its Part 1 medical trial on contributors affected by Alzheimer’s illness to proceed testing the security of IGC-AD1 at increased doses.

In accordance with World Well being Group, Alzheimer’s illness is anticipated to impression roughly 50 million people worldwide by 2030. IGC-AD1 is meant to help with symptom aid in people residing with Alzheimer’s, who might undergo from agitation, restlessness, anxiousness, irritability, apathy, disinhibition, delusions, hallucinations, and sleep or urge for food adjustments, amongst different signs. Because the illness progresses, people might undergo from lack of reminiscence and dementia. This Part 1 trial is presently testing IGC-AD1 for security. Relying on the outcomes of this primary medical trial section and pending acceptable FDA approvals, IGC intends to pursue further future trials for efficacy at a later date.

A Part 1 medical trial is step one of a human medical trial in a multi-step course of designed to acquire regulatory approval for the advertising of a brand new pharmaceutical drug. This multi-step course of for acquiring FDA approval is described in IGC’s annual report on Type 10-Okay filed with the U.S. Securities and Change Fee (“SEC”) on July 13, 2020.



[ad_2]

Source link

Previous Post

CBD and Hemp Legal and Regulatory Roundup – June 2021 #2 | Kelley Drye & Warren LLP

Next Post

ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)

Related Posts

90 oz. of marijuana, gun seized during traffic stop – WPRI.com
THC

90 oz. of marijuana, gun seized during traffic stop – WPRI.com

October 11, 2022
Criminal complaints: Sept. 20-24 | Crime and Courts
THC

Criminal complaints: Sept. 20-24 | Crime and Courts

September 26, 2021
Berner’s Cannabis Brand ‘Cookies’ Rolls Out Capsules Combining Non-Psychedelic Mushrooms & THC
THC

Berner’s Cannabis Brand ‘Cookies’ Rolls Out Capsules Combining Non-Psychedelic Mushrooms & THC

September 26, 2021
Police: Kirkwood home explosion caused by THC extraction process
THC

Police: Kirkwood home explosion caused by THC extraction process

September 26, 2021
THC

Delta 8, CBD, 1% THC, And Other Issues Affecting The Hemp Industry: A Conversation With Eric Steenstra – Cannabis & Hemp

September 26, 2021
Update / Recall: OLCC issues recall for hemp labeled product with high THC levels | News
THC

Update / Recall: OLCC issues recall for hemp labeled product with high THC levels | News

September 25, 2021

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

As Megan Rapinoe Promotes CBD Use, Sha’Carri Richardson Sits Out The Olympics

As Megan Rapinoe Promotes CBD Use, Sha’Carri Richardson Sits Out The Olympics

July 28, 2021
Things You Should Know About CBD Cannabidiol for Amazing Health

Things You Should Know About CBD Cannabidiol for Amazing Health

July 10, 2021

Popular Post

  • Keoni CBD Gummies – Shocking Side Effects Scam Complaints?

    Keoni CBD Gummies – Shocking Side Effects Scam Complaints?

    414 shares
    Share 166 Tweet 104
  • My Life With OCD: I Fear Manifesting My Thoughts

    366 shares
    Share 146 Tweet 92
  • Five Leaf Clover brings cannabidiol alternative medicine to rural South Dakota

    363 shares
    Share 145 Tweet 91
  • VpMax-9 Reviews – Scam Complaints or VpMax-9 Ingredients Really Work?

    345 shares
    Share 138 Tweet 86
  • Tesco, Supervalu, Lidl and more issue urgent safety recalls for products sold across Ireland

    342 shares
    Share 137 Tweet 86
ibodyCBD

© 2021 Copyright ibodyCBD

  • Privacy & Policy
  • About Us
  • Contact Us

No Result
View All Result
  • Home
  • CBD News
  • Wellness
    • CBD Wellness
    • CBD Anxiety
    • CBD Oil
  • Cannabis
    • Medical Marijuana
    • cbd benefits
    • CBD Health
    • THC
  • Food & Nutrition
    • keto
    • smoothies
    • herbal nutrition
  • Fitness
    • Exercise
    • Workout tips
  • Lifestyle
    • Keto diet
    • intermittent fasting
    • Hemp
    • Hemp Seed
  • Shop

© 2021 Copyright ibodyCBD